Robinson AA, Jain A, Gentry M, McNamara RL. Left ventricular thrombi after STEMI in the primary PCI era: a systematic review and meta-analysis. Int J Cardiol. 2016;221:554–9 (15 ottobre).

Article  Google Scholar 

Habash F, Vallurupalli S. Challenges in management of left ventricular thrombus. Ther Adv Cardiovasc Dis agosto. 2017;11(8):203–13.

Article  Google Scholar 

Albaeni A, Chatila K, Beydoun HA, Beydoun MA, Morsy M, Khalife WI. In-hospital left ventricular thrombus following ST-elevation myocardial infarction. Int J Cardiol. 2020;299:1–6 (15 gennaio).

Article  Google Scholar 

Di Odoardo LAF, Stefanini GG, Vicenzi M. Uncertainties about left ventricular thrombus after STEMI. Nat Rev Cardiol giugno. 2021;18(6):381–2.

Article  Google Scholar 

Levine GN, McEvoy JW, Fang JC, Ibeh C, McCarthy CP, Misra A, et al. Management of patients at risk for and with left ventricular thrombus: a scientific statement from the American Heart Association. Circulation. 2022;146(15):e205-23 (11 ottobre).

Article  Google Scholar 

Weinsaft JW, Kim J, Medicherla CB, Ma CL, Codella NCF, Kukar N, et al. Echocardiographic algorithm for post-myocardial infarction LV thrombus: a gatekeeper for thrombus evaluation by delayed enhancement CMR. JACC Cardiovasc Imaging maggio. 2016;9(5):505–15.

Article  Google Scholar 

Massussi M, Scotti A, Lip GYH, Proietti R. Left ventricular thrombosis: new perspectives on an old problem. Eur Heart J Cardiovasc Pharmacother. 2021;7(2):158–67 (15 marzo).

Article  Google Scholar 

Gellen B, Biere L, Logeart D, Lairez O, Vicaut E, Furber A, et al. Timing of cardiac magnetic resonance imaging impacts on the detection rate of left ventricular thrombus after myocardial infarction. JACC Cardiovasc Imaging novembre. 2017;10(11):1404–5.

Article  Google Scholar 

Cambronero-Cortinas E, Bonanad C, Monmeneu JV, Lopez-Lereu MP, Gavara J, de Dios E, et al. Incidence, outcomes, and predictors of ventricular thrombus after reperfused ST-segment-elevation myocardial infarction by using sequential cardiac MR imaging. Radiol Agosto. 2017;284(2):372–80.

Google Scholar 

Roifman I, Connelly KA, Wright GA, Wijeysundera HC. Echocardiography vs. cardiac magnetic resonance imaging for the diagnosis of left ventricular thrombus: a systematic review. Can J Cardiol giugno. 2015;31(6):785–91.

Article  Google Scholar 

Weinsaft JW, Kim HW, Crowley AL, Klem I, Shenoy C, Van Assche L, et al. LV thrombus detection by routine echocardiography: insights into performance characteristics using delayed enhancement CMR. JACC Cardiovasc Imaging luglio. 2011;4(7):702–12.

Article  Google Scholar 

Srichai MB, Junor C, Rodriguez LL, Stillman AE, Grimm RA, Lieber ML, et al. Clinical, imaging, and pathological characteristics of left ventricular thrombus: a comparison of contrast-enhanced magnetic resonance imaging, transthoracic echocardiography, and transesophageal echocardiography with surgical or pathological validation. Am Heart J luglio. 2006;152(1):75–84.

Article  Google Scholar 

McCarthy CP, Vaduganathan M, McCarthy KJ, Januzzi JL, Bhatt DL, McEvoy JW. Left ventricular thrombus after acute myocardial infarction: screening, prevention, and treatment. JAMA Cardiol 1 luglio. 2018;3(7):642–9.

Article  Google Scholar 

Mao TF, Bajwa A, Muskula P, Coggins TR, Kennedy K, Magalski A, et al. Incidence of left ventricular thrombus in patients with acute ST-segment elevation myocardial infarction treated with percutaneous coronary intervention. Am J Cardiol 1 gennaio. 2018;121(1):27–31.

Article  Google Scholar 

Sayed A, Ghonim M, Ghonim M, Awad AK, Saleh Y, Abdelfattah OM. Are direct oral anticoagulants preferable to warfarin for the treatment of left ventricular thrombi? A Bayesian meta-analysis of randomized controlled trials. Am Heart J Plus Cardiol Res Pract 1 dicembre. 2021;12:100066.

Article  Google Scholar 

Gibson CM, Mehran R, Bode C, Halperin J, Verheugt FW, Wildgoose P, et al. Prevention of bleeding in patients with atrial fibrillation undergoing PCI. N Engl J Med 22 dicembre. 2016;375(25):2423–34.

Article  Google Scholar 

Lopes RD, Heizer G, Aronson R, Vora AN, Massaro T, Mehran R, et al. Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation. N Engl J Med 18 aprile. 2019;380(16):1509–24.

Article  Google Scholar 

Alcalai R, Butnaru A, Moravsky G, Yagel O, Rashad R, Ibrahimli M, et al. Apixaban versus warfarin in patients with left ventricular thrombus, a prospective multicenter randomized clinical trial. Eur Heart J Cardiovasc Pharmacother. 19 luglio 2021;pvab057.

Abdelnabi M, Saleh Y, Fareed A, Nossikof A, Wang L, Morsi M, et al. Comparative study of oral anticoagulation in left ventricular thrombi (No-LVT Trial). J Am Coll Cardiol 30 marzo. 2021;77(12):1590–2.

Article  Google Scholar 

Camilli M, Lombardi M, Del Buono MG, Chiabrando JG, Vergallo R, Niccoli G, et al. Direct oral anticoagulants vs. vitamin K antagonists for the treatment of left ventricular thrombosis: a systematic review of the literature and meta-analysis. Eur Heart J Cardiovasc Pharmacother 23 maggio. 2021;7(3):e21-5.

Article  Google Scholar 

Lattuca B, Bouziri N, Kerneis M, Portal JJ, Zhou J, Hauguel-Moreau M, et al. Antithrombotic therapy for patients with left ventricular mural thrombus. J Am Coll Cardiol 14 aprile. 2020;75(14):1676–85.

Article  Google Scholar 

Robinson AA, Trankle CR, Eubanks G, Schumann C, Thompson P, Wallace RL, et al. Off-label use of direct oral anticoagulants compared with warfarin for left ventricular thrombi. JAMA Cardiol 1 giugno. 2020;5(6):685–92.

Article  Google Scholar 

Vaitkus PT, Barnathan ES. Embolic potential, prevention and management of mural thrombus complicating anterior myocardial infarction: a meta-analysis. J Am Coll Cardiol ottobre. 1993;22(4):1004–9.

Article  Google Scholar 

Nikolsky E, Mehran R, Dangas GD, Yu J, Parise H, Xu K, et al. Outcomes of patients treated with triple antithrombotic therapy after primary percutaneous coronary intervention for ST-elevation myocardial infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial). Am J Cardiol 15 marzo. 2012;109(6):831–8.

Article  Google Scholar 

Le May MR, Acharya S, Wells GA, Burwash I, Chong AY, So DY, et al. Prophylactic warfarin therapy after primary percutaneous coronary intervention for anterior ST-segment elevation myocardial infarction. JACC Cardiovasc Interv gennaio. 2015;8(1 Pt b):155–62.

Article  Google Scholar 

Shavadia JS, Youngson E, Bainey KR, Bakal J, Welsh RC. Outcomes and prognostic impact of prophylactic oral anticoagulation in anterior st-segment elevation myocardial infarction patients with left ventricular dysfunction. J Am Heart Assoc 3 luglio. 2017;6(7):e006054.

Article  Google Scholar 

Zhang Z, Si D, Zhang Q, Jin L, Zheng H, Qu M, et al. Prophylactic rivaroxaban therapy for left ventricular thrombus after anterior st-segment elevation myocardial infarction. JACC Cardiovasc Interv aprile. 2022;15(8):861–72.

Article  Google Scholar